Member Company


Mintz understands the business of digital health, the evolving nature of the industry, and the complex federal and state legislative, regulatory, and reimbursement environment within which digital health companies operate. 

We have over 20 years of experience and exceptional technical depth in representing digital health clients — where our core practice strengths in health law, FDA, reimbursement (including CMS and private payer negotiations), technology transactions, IP, data privacy and security, mergers and acquisitions, and financing converge. We represent both companies and investors in the sector and always look to connect members of our ecosystem with each other. We work in cross-practice client service teams built to be responsive to each company’s unique needs, market position, and business goals.

We also leverage the political experience of our government affairs affiliate, ML Strategies, to assist clients throughout the health care industry. Our bipartisan team of lobbyists work with organizations in health technology, medical devices, pharmaceuticals, and providers to advance their legislative and regulatory priorities. ML Strategies works across Congress, with particular focus on the committees of health care jurisdiction, as well as the FDA and CMS. With extensive experience in regulation and reimbursement policy, ML Strategies is well-positioned to work in tandem with Mintz to deliver results for digital health organizations. 

With this broad base and depth of experience, we provide comprehensive counsel to digital health clients ranging from start-ups to Fortune 100 companies as unprecedented investment and consumer demand for innovative delivery models and access to health care data drive the industry forward.

Copyright © 2024 Digital Therapeutics Alliance™